Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

WOCKHARDT BIO AG

  • FDA Approval
  • April 20, 2023, 11:40 UTC
  • 35
  • 0 comments

FDA approve ACETAMINOPHEN

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • April 20, 2023, 11:40 UTC
  • 31
  • 0 comments

FDA approve RIBAVIRIN

Comment Full text

XIROMED

  • FDA Approval
  • April 20, 2023, 11:40 UTC
  • 34
  • 0 comments

FDA approve BETAMETHASONE VALERATE

Comment Full text

GALDERMA LABS LP

  • FDA Approval
  • April 20, 2023, 11:40 UTC
  • 34
  • 0 comments

FDA approve ADAPALENE

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • April 20, 2023, 11:40 UTC
  • 32
  • 0 comments

FDA approve ROFLUMILAST

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • April 20, 2023, 11:40 UTC
  • 34
  • 0 comments

FDA approve CEVIMELINE HYDROCHLORIDE

Comment Full text

TORRENT

  • FDA Approval
  • April 20, 2023, 11:40 UTC
  • 33
  • 0 comments

FDA approve CETIRIZINE HYDROCHLORIDE

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • April 20, 2023, 11:40 UTC
  • 32
  • 0 comments

FDA approve ROFLUMILAST

Comment Full text

HIKMA

  • FDA Approval
  • April 20, 2023, 11:40 UTC
  • 32
  • 0 comments

FDA approve CLOBAZAM

Comment Full text

ACTAVIS LABS FL INC

  • FDA Approval
  • April 20, 2023, 11:40 UTC
  • 132
  • 0 comments

FDA approve DALFAMPRIDINE

Comment Full text
  • Previous
  • 837
  • 838
  • 839
  • 840
  • 841
  • Next

Search

News categories

  • Technical Exchange News(14775)
  • Event(6229)
  • SEC News(398991)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(243084)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin